Skip to main content
. 2023 Jan 2;11(1):e005493. doi: 10.1136/jitc-2022-005493

Figure 2.

Figure 2

Timeline with median onset-timing (in months, mo.) (IQR) of the different organ-specific irAEs. ICI, immune checkpoint inhibitor; irAEs, immune-related adverse events.